About this episode

Chadi discusses the RASolute 302 trial findings with leading gastrointestinal oncologists.

Chadi is joined by renowned gastrointestinal oncologists, Tanios S. Bekaii-Saab, MD, of Mayo Clinic, and Shubham Pant, MD, MBBS, of MD Anderson Cancer Center, to discuss the groundbreaking findings from the RASolute 302 trial, recently published in The New England Journal of Medicine and presented to a standing ovation during the plenary session at the 2026 ASCO Annual Meeting. Dr. Pant, a study author, provides an insider's perspective on how RAS inhibition is reshaping the treatment landsca...

People in this episode

Host: Chadi Nabhan

Guests: Tanios S. Bekaii-Saab, MD, Shubham Pant, MD, MBBS

Topics covered

• pancreatic cancer
• RAS inhibition
• oncology
• clinical trials
• medical research

Keywords

• RASolute 302
• pancreatic cancer
• clinical trial
• oncology
• RAS inhibition

Mentioned in this episode

Organizations: Mayo Clinic, MD Anderson Cancer Center, The New England Journal of Medicine

More episodes of Healthcare Unfiltered

• Episode 288 - Leadership Lessons: From Bunker Hill to the Boardroom · July 21, 2026 · 53 min
• Episode 286: The Status of NGS in Cancer With Ezra Cohen · July 7, 2026 · 41 min
• LOS DIFERENTES SIGNIFICADOS DE LA PALABRA CÁNCER EN HEMATOLOGÍA · July 1, 2026 · 44 min
• Episode 285 - Gabby’s Journey: Cancer, Hope, and Resilience · June 30, 2026 · 47 min
• Episode 284: The Evolution of Liver Transplant for Cancer With Maen Abdelrahim · June 23, 2026 · 39 min
• Episode 283 - MAID in America: Navigating Choice, Compassion, and Controversy · June 16, 2026 · 51 min

Explore listener stats, chart rankings, contacts and more on the Healthcare Unfiltered podcast page.